| Serial Number | 90105761 |
| Word Mark | AM ANTAROS MEDICAL |
| Filing Date | Tuesday, August 11, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 2, 2021 |
| Registration Number | 6542462 |
| Registration Date | Tuesday, November 2, 2021 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 17, 2021 |
| Description of Mark | The mark consists of the stylized letters "AM" with the letter "A" made up of a light blue arch, a red arch, and a dark blue rectangle, and with the letter "M" made up of a purple arch, a pink rectangle and a green rectangle, all appearing in larger font to the left of the stacked stylized words "ANTAROS MEDICAL" in black. The white represents background and is not a feature of the mark. |
| Indication of Colors claimed | The color(s) green, light blue, dark blue, purple, red, pink, and black is/are claimed as a feature of the mark. |
| Goods and Services | x-ray technician services; medical evaluation services for pharmaceutical research and development; medical imaging services; advisory services relating to medical services; advisory services relating to pharmaceuticals; issuing of medical reports in the field of pharmaceutical research and development; compilation of data in the nature of medical reports for diagnostic purposes; conducting of medical examinations for pharmaceutical research and development; x-ray examinations for medical purposes; medical diagnostic services; preparation of reports relating to medical matters for pharmaceutical research and development; advisory services relating to medical instruments; all the aforesaid services in this class being used for providing medical information on the development of pharmaceuticals |
| Disclaimer with Predetermined Text | "MEDICAL" |
| Goods and Services | Consultancy relating to drug development; drug discovery services; consultancy relating to pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to scientific research focusing on imaging and development of pharmaceuticals; scientific research for development of pharmaceuticals and for medical purposes; pharmaceuticals research relating to imaging; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; pharmaceutical drug development services; pharmaceutical research services; industrial analysis and research services in the field of pharmaceuticals; biochemistry research services; provision of information and data relating to medical and veterinary pharmaceutical research and development; preparing and providing medical and scientific research information and reports in relation to pharmaceuticals and clinical tests; research and development relating to imaging for the pharmaceuticals industry; conducting clinical trials, for others; conducting clinical trials for pharmaceutical products for others; clinical research relating to imaging; medical research relating to imaging; scientific research relating to imaging; development of test methods, namely, specifications, procedures, and techniques relating to imaging; research and development relating to imaging; scientific research and development relating to imaging; scientific research and analysis in the field of development of pharmaceuticals; development in relation to methods, namely, specifications, procedures, and techniques for testing relating to imaging; services relating to pharmaceutical research and development relating to imaging; research and development in the pharmaceuticals and biotechnology fields relating to imaging; scientific and technological services relating to imaging, namely, research; scientific services and design relating thereto relating to imaging, namely clinical research in the field of pharmaceuticals; scientific services and research relating thereto relating to imaging, namely clinical research in the field of pharmaceuticals; analytical laboratory services, namely, medical imaging analysis; testing, authentication and quality control in the field of pharmaceuticals, for others; quality assurance consultancy in the field of pharmaceuticals; clinical study design services; pharmaceutical drug development services, namely, analysis of X-ray images for drug development; compilation of data in the nature of medical reports for research purposes |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 14, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 14, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Antaros Medical AB |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Mölndal SE-43183 SE |
| Party Name | Antaros Medical AB |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Mölndal SE-43183 SE |
| Party Name | Antaros Medical AB |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Mölndal SE-43183 SE |
| Event Date | Event Description |
| Friday, November 17, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, November 17, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, November 17, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, November 17, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, November 17, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, November 2, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 17, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 17, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 28, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 13, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, May 7, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, May 7, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 7, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, December 6, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, December 6, 2020 | NON-FINAL ACTION E-MAILED |
| Sunday, December 6, 2020 | NON-FINAL ACTION WRITTEN |
| Saturday, December 5, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, September 15, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, September 14, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 14, 2020 | NEW APPLICATION ENTERED |